Delivery Order SPE2DB20D1100-SPE2DB25FE5A7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 with a ceiling value of $4,186.92. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $35,598.54 under a firm fixed price structure. The award, issued on September 25, 2025, is non-competitive and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $1,522.56. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,276.48 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical will be sourced from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ondansetron HCl 8 mg tablets (30-count units) with a ceiling value of $7,423.50. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The award represents a single delivery order drawn...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitive, non-set-aside delivery order carries a ceiling value of approximately $15.1K with firm fixed pricing and is scheduled for completion by September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and leverages its established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ondansetron HCL 8 mg tablets (30-count) with a contract ceiling value of approximately $43K. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 25, 2025. AmerisourceBergen will perform the work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 tablets, with a ceiling value of $20,173.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and is scheduled for completion by August 8, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,956.09 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 units. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5A7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 units, with a contract ceiling value of approximately $27.9K. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9M vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and broader military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products including specialty medications, generics, vaccines, and medical supplies across multiple therapeutic domains. All reviewed contract awards with this vendor reflect competitively awarded, non-set-aside procurements utilizing firm fixed-price structures, underscoring AmerisourceBergen's capability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 9/5/25 |